Find comprehensive information on Gastric Ulcer Disease diagnosis, including clinical documentation requirements, ICD-10 codes K25 and related codes, medical coding guidelines, and healthcare best practices for accurate diagnosis and treatment. Learn about peptic ulcer disease, gastritis, H pylori infection testing, endoscopic findings, and symptom management for optimal patient care. This resource provides essential details for physicians, nurses, coders, and other healthcare professionals involved in the diagnosis and management of gastric ulcers.
Also known as
Gastric and duodenal ulcer
Covers all types of ulcers affecting the stomach and duodenum.
Gastric ulcer
Specifies ulcers located in the stomach, excluding the pylorus.
Duodenal ulcer
Specifies ulcers occurring in the duodenum.
Peptic ulcer NOS
Used for peptic ulcers not otherwise specified as gastric or duodenal.
Follow this step-by-step guide to choose the correct ICD-10 code.
Active bleeding from gastric ulcer?
Yes
Site of active bleed specified?
No
Ulcer is perforated?
When to use each related code
| Description |
|---|
| Gastric ulcer |
| Duodenal ulcer |
| Gastroesophageal reflux disease (GERD) |
Q: What are the most effective triple therapy regimens for H. pylori-associated gastric ulcer disease in penicillin-allergic patients?
A: For penicillin-allergic patients with H. pylori-associated gastric ulcer disease, effective triple therapy regimens typically involve a proton pump inhibitor (PPI) like omeprazole or lansoprazole, metronidazole, and clarithromycin. Alternatively, bismuth quadruple therapy, consisting of a PPI, bismuth subsalicylate, metronidazole, and tetracycline, is another viable option. The choice between these regimens depends on local resistance patterns and patient-specific factors like comorbidities and medication interactions. Consider implementing antibiotic susceptibility testing when possible to tailor treatment and improve eradication rates. Explore how regional resistance patterns influence treatment selection for H. pylori.
Q: How can I differentiate between gastric ulcer and gastric cancer during endoscopic evaluation, and what are the key diagnostic features to look for?
A: Differentiating between gastric ulcer and gastric cancer during endoscopy requires careful assessment of several key features. Benign ulcers typically present with regular, smooth margins, a clean base, and radiating folds converging towards the ulcer crater. In contrast, malignant ulcers often exhibit irregular, raised, or nodular margins, a necrotic or friable base, and disrupted or clubbed surrounding folds. Furthermore, the location, size, and appearance of the ulcer can provide valuable clues. While endoscopic appearance can be suggestive, histopathological examination of biopsies obtained during endoscopy remains the gold standard for definitive diagnosis. Learn more about advanced endoscopic imaging techniques like narrow-band imaging or confocal laser endomicroscopy that can aid in differentiating between benign and malignant lesions.
Patient presents with complaints consistent with gastric ulcer disease, including epigastric pain, burning sensation in the stomach, nausea, and indigestion. Symptoms are described as gnawing or aching and often occur between meals or during the night. Patient reports symptom relief with antacids. On physical examination, tenderness to palpation in the epigastric region was noted. Differential diagnosis includes peptic ulcer disease, gastritis, gastroesophageal reflux disease (GERD), and functional dyspepsia. Diagnostic workup may include esophagogastroduodenoscopy (EGD) with biopsy to visualize the ulcer and rule out Helicobacter pylori infection, urea breath test, or stool antigen test. Assessment includes evaluating for risk factors such as NSAID use, smoking history, and family history of ulcers. Plan includes initiating proton pump inhibitor (PPI) therapy for acid suppression, H. pylori eradication therapy if indicated, lifestyle modifications such as smoking cessation and dietary adjustments, and follow-up EGD to assess ulcer healing. Patient education provided on medication management, potential complications such as bleeding and perforation, and importance of adherence to the treatment plan. ICD-10 code K25.x will be used for billing purposes, with specific code selection dependent upon ulcer location and characteristics documented. CPT codes for procedures performed, such as EGD (43239) or biopsy (43239), will also be included for appropriate medical billing and coding. Follow-up scheduled in four to eight weeks to assess response to treatment and monitor for any complications.